157 related articles for article (PubMed ID: 8801580)
1. The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence.
Popik P; Skolnick P
Pharmacol Biochem Behav; 1996 Apr; 53(4):791-7. PubMed ID: 8801580
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment with morphine potentiates naloxone-conditioned place aversion in mice: effects of NMDA receptor antagonists.
Blokhina EA; Sukhotina IA; Bespalov AY
Eur J Pharmacol; 2000 Oct; 406(2):227-32. PubMed ID: 11020485
[TBL] [Abstract][Full Text] [Related]
3. Effects of N-methyl-D-aspartate receptor antagonists on discriminative stimulus effects of naloxone in morphine-dependent rats using the Y-maze drug discrimination paradigm.
Medvedev IO; Dravolina OA; Bespalov AY
J Pharmacol Exp Ther; 1998 Sep; 286(3):1260-8. PubMed ID: 9732387
[TBL] [Abstract][Full Text] [Related]
4. The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans.
Bisaga A; Comer SD; Ward AS; Popik P; Kleber HD; Fischman MW
Psychopharmacology (Berl); 2001 Aug; 157(1):1-10. PubMed ID: 11512037
[TBL] [Abstract][Full Text] [Related]
5. Effects of the NMDA receptor antagonist, D-CPPene, on sensitization to the operant decrement produced by naloxone in morphine-treated rats.
Bespalov AY; Medvedev IO; Sukhotina IA; Zvartau EE
Behav Pharmacol; 2001 Apr; 12(2):135-42. PubMed ID: 11396518
[TBL] [Abstract][Full Text] [Related]
6. Memantine presents different effects from MK-801 in motivational and physical signs of morphine withdrawal.
Maldonado C; Cauli O; Rodríguez-Arias M; Aguilar MA; Miñarro J
Behav Brain Res; 2003 Sep; 144(1-2):25-35. PubMed ID: 12946592
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists.
Popik P; Mamczarz J; Fraczek M; Widła M; Hesselink M; Danysz W
Neuropharmacology; 1998 Aug; 37(8):1033-42. PubMed ID: 9833632
[TBL] [Abstract][Full Text] [Related]
8. Effects of the NMDA receptor antagonist memantine on the expression and development of acute opiate dependence as assessed by withdrawal-potentiated startle and hyperalgesia.
Harris AC; Rothwell PE; Gewirtz JC
Psychopharmacology (Berl); 2008 Mar; 196(4):649-60. PubMed ID: 18026718
[TBL] [Abstract][Full Text] [Related]
9. Morphine tolerance and dependence in mice with history of repeated exposures to NMDA receptor channel blockers.
Dravolina OA; Belozertseva IV; Sukhotina IA; Bespalov AY
Pharmacol Biochem Behav; 1999 Aug; 63(4):613-9. PubMed ID: 10462190
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice.
Kozela E; Pilc A; Popik P
Psychopharmacology (Berl); 2003 Jan; 165(3):245-51. PubMed ID: 12442203
[TBL] [Abstract][Full Text] [Related]
11. Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice.
Popik P; Kozela E; Danysz W
Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):425-32. PubMed ID: 10763858
[TBL] [Abstract][Full Text] [Related]
12. Excitatory amino acid receptor antagonists and naloxone-precipitated withdrawal syndrome in morphine-dependent mice.
Cappendijk SL; de Vries R; Dzoljic MR
Eur Neuropsychopharmacol; 1993 Jun; 3(2):111-6. PubMed ID: 8395919
[TBL] [Abstract][Full Text] [Related]
13. The effect of the glycine/NMDA receptor antagonist, (+)-HA966, on morphine dependence in neuropathic rats.
Christensen D; Guilbaud G; Kayser V
Neuropharmacology; 2000 Jul; 39(9):1589-95. PubMed ID: 10854903
[TBL] [Abstract][Full Text] [Related]
14. Clinically available NMDA antagonist, memantine, attenuates tolerance to analgesic effects of morphine in a mouse tail flick test.
Popik P; Kozela E
Pol J Pharmacol; 1999; 51(3):223-31. PubMed ID: 10600036
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of morphine dependence and withdrawal by glycine B site antagonists in rats.
Kotlińska J
Pharmacol Biochem Behav; 2001 Jan; 68(1):157-61. PubMed ID: 11274720
[TBL] [Abstract][Full Text] [Related]
16. NMDA antagonist properties of the putative antiaddictive drug, ibogaine.
Popik P; Layer RT; Fossom LH; Benveniste M; Geter-Douglass B; Witkin JM; Skolnick P
J Pharmacol Exp Ther; 1995 Nov; 275(2):753-60. PubMed ID: 7473163
[TBL] [Abstract][Full Text] [Related]
17. Antinociceptive activity of combination of morphine and NMDA receptor antagonists depends on the inter-injection interval.
Belozertseva IV; Dravolina OA; Neznanova ON; Danysz W; Bespalov AY
Eur J Pharmacol; 2000 May; 396(2-3):77-83. PubMed ID: 10822059
[TBL] [Abstract][Full Text] [Related]
18. Interaction of memantine and ketamine in morphine- and pentazocine-induced antinociception in mice.
Malec D; Mandryk M; Fidecka S
Pharmacol Rep; 2008; 60(2):149-55. PubMed ID: 18443375
[TBL] [Abstract][Full Text] [Related]
19. Acute and chronic heroin dependence in mice: contribution of opioid and excitatory amino acid receptors.
Klein G; Juni A; Arout CA; Waxman AR; Inturrisi CE; Kest B
Eur J Pharmacol; 2008 May; 586(1-3):179-88. PubMed ID: 18343363
[TBL] [Abstract][Full Text] [Related]
20. Peripherally acting NMDA receptor/glycineB site receptor antagonists inhibit morphine tolerance.
Danysz W; Kozela E; Parsons CG; Sladek M; Bauer T; Popik P
Neuropharmacology; 2005 Mar; 48(3):360-71. PubMed ID: 15721168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]